Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 3/20 | 0.49 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.49 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.49 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.49 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.49 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5077431 | 1.00 | TSHR (0.56) | TSHRALDH1A1LMNAMAPK1TP53 | |
| SCHEMBL2243440 | 1.00 | TSHR (0.56) | TSHRALDH1A1LMNAMAPK1TP53 | |
| SCHEMBL6029882 | 1.00 | TSHR (0.56) | TSHRALDH1A1LMNAMAPK1TP53 | |
| SCHEMBL5080112 | 1.00 | TSHR (0.56) | TSHRALDH1A1LMNAMAPK1TP53 | |
| SCHEMBL5083670 | 1.00 | TSHR (0.56) | TSHRALDH1A1LMNAMAPK1TP53 | |
| SCHEMBL5080126 | 1.00 | TSHR (0.56) | TSHRALDH1A1LMNAMAPK1TP53 | |
| SCHEMBL2238417 | 0.98 | TSHR (0.55) | TSHRALDH1A1LMNAMAPK1TP53 | |
| SCHEMBL5079224 | 0.83 | ALDH1A1 (0.66) | TSHRALDH1A1LMNAESR1AKR1C4 | |
| SCHEMBL3684491 | 0.83 | TSHR (0.51) | TSHRALDH1A1LMNAMAPK1TP53 | |
| SCHEMBL3676153 | 0.83 | TSHR (0.51) | TSHRALDH1A1LMNAMAPK1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1238704-B1 | Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst | DAICEL CHEM (JP) | 2015-01-21 | — | — | EP | disclosed |
| US-7368615-B2 | Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2008-05-06 | — | — | US | disclosed |
| US-20060036100-A1 | Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst | ISHII YASUTAKA | 2006-02-16 | — | — | US | disclosed |
| US-6998491-B2 | Catalyst comprising a cyclic imide compound | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2006-02-14 | — | — | US | disclosed |
| US-20020128149-A1 | Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2002-09-12 | — | — | US | disclosed |
| EP-1238704-A2 | Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst | Daicel Chemical Industries, Ltd. (JP) | 2002-09-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020128149-A1 | Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst | NOX4, POR, NOX1 | TSHR 3340/4885ALDH1A1 1339/4885LMNA 3854/4885 |
| US-20060036100-A1 | Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst | NOX4, NOX1, POR | TSHR 3276/4885ALDH1A1 1439/4885LMNA 3862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.